Research location
Akita
Japan
Advertisement
Research activity in Akita
JapanCureCurrent currently publishes aggregate city-level research activity for this location: 65 trials and 81 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Akita
65 linked trials · page 1 of 2Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer (JCOG2402, Young HOPE)NCT07671885 · 2026-01-28 · 1 site observation
RECRUITING
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)NCT07060807 · 2025-07-21 · 1 site observation
RECRUITING
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)NCT06966700 · 2025-06-30 · 1 site observation
RECRUITING
A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease DementiaNCT06803823 · 2025-05-01 · 2 site observations
RECRUITING
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)NCT06841354 · 2025-03-16 · 1 site observation
RECRUITING
Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)NCT06659393 · 2024-12-19 · 1 site observation
RECRUITING
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)NCT06136624 · 2023-12-31 · 1 site observation
RECRUITING
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)NCT06136650 · 2023-12-18 · 1 site observation
RECRUITING
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's DiseaseNCT06538116 · 2024-08-26 · 1 site observation
COMPLETED
Special Use - Results Surveillance on Long-term Use With Wegovy®NCT06283667 · 2024-06-11 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic RetinopathyNCT06321302 · 2024-05-15 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast CancerNCT06112379 · 2023-11-14 · 1 site observation
ACTIVE_NOT_RECRUITING
TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)NCT05729711 · 2023-04-04 · 1 site observation
ACTIVE_NOT_RECRUITING
LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)NCT05677308 · 2023-03-07 · 1 site observation
COMPLETED
A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal TherapyNCT05303558 · 2022-08-24 · 1 site observation
COMPLETED
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid TumorsNCT05101096 · 2021-10-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Forxiga HF General Drug Use-Results StudyNCT04865406 · 2021-05-10 · 1 site observation
COMPLETED
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension PhaseNCT04825860 · 2021-03-29 · 1 site observation
TERMINATED
Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine MonotherapyNCT04736576 · 2021-02-24 · 1 site observation
COMPLETED
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic PhenotypeNCT04718389 · 2021-01-26 · 1 site observation
COMPLETED
Long Term Special Drug Use-results Surveillance for Mayzent in SPMS PatientsNCT04593927 · 2020-10-28 · 1 site observation
COMPLETED
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®NCT04469855 · 2020-07-27 · 3 site observations
COMPLETED
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid ArthritisNCT03971253 · 2019-09-02 · 1 site observation
COMPLETED
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in JapanNCT04034095 · 2019-07-08 · 1 site observation
COMPLETED
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyNCT03767244 · 2019-06-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)NCT03898180 · 2019-05-06 · 1 site observation
COMPLETED
IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation TherapyNCT03643484 · 2018-10-24 · 1 site observation
COMPLETED
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)NCT03645330 · 2018-08-15 · 1 site observation
COMPLETED
FASENRA SCEI for Long-term UseNCT03588546 · 2018-05-31 · 1 site observation
COMPLETED
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate CancerNCT03456843 · 2018-03-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)NCT03260894 · 2017-12-07 · 1 site observation
COMPLETED
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)NCT03142334 · 2017-06-09 · 1 site observation
COMPLETED
A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With HypertensionNCT02791438 · 2016-08-18 · 1 site observation
COMPLETED
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal DiseaseNCT02512068 · 2015-08-07 · 1 site observation
COMPLETED
A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease ParticipantsNCT02337751 · 2015-07-10 · 1 site observation
COMPLETED
A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease PatientsNCT02337725 · 2015-02-07 · 1 site observation
COMPLETED
A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease ParticipantsNCT02337738 · 2015-01-27 · 1 site observation
COMPLETED
Long-Term Specified Drug Use-Results Survey for Xtandi CapsuleNCT02669771 · 2014-11-30 · 1 site observation
COMPLETED
Forxiga Tablets Specific Clinical Experience Investigation for Long-term UseNCT02200666 · 2014-10-03 · 1 site observation
COMPLETED
Forxiga Tablets Specific Clinical Experience Investigation for ElderlyNCT02200627 · 2014-09-01 · 1 site observation
COMPLETED
Specific Clinical Experience Investigation for Long-term Use of Bydureon.NCT01940770 · 2013-10-18 · 1 site observation
COMPLETED
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate CancerNCT01946204 · 2013-10-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.NCT01929317 · 2013-08-28 · 1 site observation
TERMINATED
Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT01713075 · 2012-11-01 · 1 site observation
COMPLETED
Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid ArthritisNCT01850966 · 2012-09-12 · 1 site observation
COMPLETED
Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's DiseaseNCT01539031 · 2012-03-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive EpisodesNCT01725308 · 2012-02-07 · 1 site observation
COMPLETED
Faslodex Specific Clinical Experience InvestigationNCT01501266 · 2012-02-01 · 1 site observation
COMPLETED
Phase 3 IGIV, 10% in Alzheimer´s DiseaseNCT01524887 · 2012-01-23 · 1 site observation
TERMINATED
Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From DonepezilNCT01478633 · 2011-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.